Skip to content
PICO Portalanswers from OpenAlex

The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication

PaperCitations, authors & open-access status

The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication is a paper indexed in PICO Portal from OpenAlex.

How many citations does The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication have?

PICO Portalcitation count

The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication has 54 citations in the OpenAlex counts PICO Portal stores.

When was The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication published?

PICO Portalyear

The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication has 2017 year in the PICO Portal index.

What is the open-access status of The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication?

PICO Portaloa status

The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication has diamond oa status in the PICO Portal index.

What is the DOI of The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication?

PICO Portaldoi

The DOI for The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication is on the source record.

What is the PMID of The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication?

PICO Portalpmid

The PMID for The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication is on the source record.

What is the OpenAlex record for The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication?

PICO Portalopenalex

The OpenAlex for The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial